Theotikos, Evangelos et al.Abstract
Gout is an autoinflammatory disease caused by monosodium urate mono hydrate crystal deposition in tissues or the supersaturation of extracellular fluids of uric acid. In this study, we are going to report the experience of the Asklepeion Voula Rheumatology Clinic, treating four patients with gouty arthritis who received Canakinumab.
Theotikos, Evangelos et al. “The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece.” Mediterranean journal of rheumatology vol. 28,1 48-51. 28 Mar. 2017,
https://doi.org/10.31138/mjr.28.1.48
*Anakinra is not registered for Gout indication in Israel